Status Covid-19/Flu A&B

Description

StatusTM COVID-19/Flu A&B
A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SAR-CoV-2, Influenza
TypeA and Type B Antigen from anterior nasal and nasopharyngeal swab specimens

• COVID-19 Anterior nasal swab specimen – Sensitivity 93.8%, Specificity 100%
• COVID-19 Nasopharyngeal – Sensitivity 93.1%, Specificity 100%
• Flu A – Sensitivity 91.4%, Specificity 95.7%
• Flu B – Sensitivity 87.6%, Specificity 95.9%
• FDA Emergency Use Authorization (EUA)
• Visually read in 15 minutes
• Flocked nasopharyngeal swab for superior specimen collection and patient comfort